Guido Kroemer

Guido Kroemer, MD, PhD, PU-PH

Scientific Advisory Board 

Dr. Guido Kroemer has made important contributions to medical research through his groundbreaking work in the fields of cell biology and cancer research. He is best known for the discovery that the permeabilization of mitochondrial membranes constitutes a decisive step in programmed cell death. His work has had far reaching implications for the comprehension, detection, and therapeutic manipulation of cellular demise.

Dr. Kroemer is a molecular biologist, immunologist, professor, and director of the European Research Institute for Integrated Cellular Pathology at the Paris Descartes University Faculty of Medicine. He is director of the Apoptosis, Cancer, and Immunity research unit at the Institut National de la Santé et de La Recherche Médical (INSERM), Director of the Metabolomics and Cell Biology Units at the Gustav Roussy Institute, and Doctor at the Hôpital Européen George Pompidou in Paris.

Dr. Kroemer’s contributions have been recognized with numerous awards. He was elected a member of German Academy of Sciences (Leopoldina) and received the organization's Carus Medal. He was named a fellow of the European Academy of Sciences. He has received the Léopold Griffuel Prize of the French Association for Cancer Research an Advanced Investigator Award from the European Research Council, the Mitjavile Prize of the French Academy of Medicine, the Galien Prize for Pharmacological Resarch, the Grand Prix Claude Bernard of the City of Paris (2, the Brupbacher Prize for Cancer Research, the ADPS Longevity Research Award, the Baillet-Latour Health Prize and the international Lombardia è Ricerca Prize among others.

Guido Kroemer currently serves on the Editorial Boards of Cell Death & Differentiation, Cell Research, EMBO Journal, EMBO Molecular Medicine, Molecular & Cellular Biology, and Science Signaling. Kroemer is also the Editor-in-Chief of four journals, Cell Stress, OncoImmunology, Microbial Cell, and Molecular & Cellular Oncology. He is member of the European Molecular Biology Organization (EMBO), Austrian Academy of Sciences, Academia Europaea, European Academy of Sciences (EAS), European Academy of Sciences and Arts (EASA), European Academy of Cancer Sciences (EACS), and Institut Universitaire de France (IUF). He is the Director of the Paris Alliance of Cancer Research Institutes (PACRI), the Founding Director of the European Research Institute for Integrated Cellular Pathology (ERI-ICP), and the Founding President of the European Academy of Tumor Immunology (EATI).